The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape
Interleukin-33 (IL-33), a member of the IL-1 cytokine family, plays a critical role in maintaining tissue homeostasis as well as pathological conditions, such as allergy, infectious disease, and cancer, by promoting type 1 and 2 immune responses. Through its specific receptor ST2, IL-33 exerts multi...
Main Authors: | Mi-Ran Choi, Jeffrey A. Sosman, Bin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3281 |
Similar Items
-
IL-33 at the Crossroads of Metabolic Disorders and Immunity
by: Lei Tu, et al.
Published: (2019-01-01) -
Predicting Immuno-Metabolic Complications After Allogeneic Hematopoietic Cell Transplant with the Cytokine Interleukin-33 (IL-33) and its Receptor Serum-Stimulation 2 (ST2)
by: Uttam K. Rao, et al.
Published: (2020-05-01) -
The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications
by: Nathan Ryan, et al.
Published: (2020-04-01) -
Blockade of IL‐33 signalling attenuates osteoarthritis
by: Zengliang He, et al.
Published: (2020-01-01) -
Contribution of IL-33 to the Pathogenesis of Colorectal Cancer
by: Guanglin Cui, et al.
Published: (2018-11-01)